of a fast paced organization. About Our Client The company is a top player in the retail industry, with over.... Excellent skills and attention to detail. Strong problem-solving abilities. A good knowledge of the retail industry. High...
Want to be part of the fastest-growing startup that is at the intersection of Retail, Fintech, and Data? Qashier... about commerce, retail, and payments, and the opportunity to transform these industries with data and technology...
Want to be part of the fastest growing start-up that is at the intersection of Retail, Fintech and Data? Qashier... is looking for an excellent Compliance Officer to support our growth!We are a dynamic and fast-growing team that is excited about commerce, retail...
Want to be part of the fastest growing startup that is at the intersection of Retail, Fintech and Data? Qashier... about commerce, retail and payments, and the opportunity to transform these industries with data and technology...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »